Dow Up 0.73% Nasdaq Up 0.60%

CytRx Corporation (CYTR)

-NasdaqCM
0.42 Up 0.00(0.12%) Mar 28, 4:00PM EDT
Prev Close:0.42
Open:0.42
Bid:N/A
Ask:0.43 x 9500
1y Target Est:2.38
Beta:1.71327
Earnings Date:May 9 - May 15 (Est.)
Day's Range:0.41 - 0.42
52wk Range:0.36 - 3.66
Volume:521,291
Avg Vol (3m):1,153,420
Market Cap:49.33M
P/E (ttm):N/A
EPS (ttm):-0.63
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRUp 0.12%49.33M
LLYUp 0.61%89.21B
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):246.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-17) :-0.50
Quarterly EPS Est (Mar-17) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is the aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback